Quite trueregarding the respective revenue growth rates.
But then againPolonovo with a market cap over $1.6b is valued at around 80 x revenue, whereas Aroa with a market cap of $225.0m is currently valued at around 9 x revenue.
IMO Aroa wasconservatively priced at the ipo and a future valuation of 20 x revenue, (marketcap = $500.0m) in the near term is not out of the question. Subject to the impacts of covid19 on revenue.
- Forums
- IPOs
- Aroa Biosurgery IPO
Quite trueregarding the respective revenue growth rates.But then...
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
BGD
BARTON GOLD HOLDINGS LIMITED
Alex Scanlon, Managing Director & CEO
Alex Scanlon
Managing Director & CEO
SPONSORED BY The Market Online